MDxHealth (MDXH) Invested Capital (2020 - 2026)

MDxHealth has disclosed Invested Capital across 7 years of filings, most recently posting $75.7 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $75.7 million, down 6.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.7 million (down 6.91% YoY), and the FY2025 annual result was $141.2 million, down 6.33% from the prior year.
• Invested Capital came in at $75.7 million for Q1 2026 at MDxHealth, down from $141.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $84.7 billion in Q2 2025 to a low of $34.8 million in Q1 2024.
• The 5-year median for Invested Capital is $67.7 million (2025), against an average of $5.7 billion.
• Across the five-year window, Invested Capital slumped 38.86% in 2022 and soared 199100.0% in 2025, its largest moves.
• MDxHealth's Invested Capital stood at $44.2 million in 2022, then soared by 179.09% to $123.4 million in 2023, then increased by 22.14% to $150.8 million in 2024, then retreated by 6.33% to $141.2 million in 2025, then plunged by 46.38% to $75.7 million in 2026.
• The last three Invested Capital figures came in at $75.7 million (Q1 2026), $141.2 million (Q4 2025), and $67.7 million (Q3 2025), per Business Quant data.